Colzi, A <br/><br/>
Continuous subcutaneous waking day apomorphine in the long term treatment of levodopa induced interdose dyskinesias in Parkinson's disease.  [electronic resource] 

 -  Journal of neurology, neurosurgery, and psychiatry  May 1998 
 - 573-6 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0022-3050 
<br/><br/><label>Standard No.: </label>10.1136/jnnp.64.5.573  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antiparkinson Agents--administration & dosage<br/>Apomorphine--administration & dosage<br/>Chronotherapy<br/>Dopamine Agonists--administration & dosage<br/>Dose-Response Relationship, Drug<br/>Drug Therapy, Combination<br/>Dyskinesia, Drug-Induced--drug therapy<br/>Female<br/>Humans<br/>Infusion Pumps, Implantable<br/>Injections, Subcutaneous<br/>Levodopa--administration & dosage<br/>Male<br/>Middle Aged<br/>Neurologic Examination--drug effects<br/>Parkinson Disease--drug therapy<br/>Treatment Outcome